Verition Fund Management’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-44,220
| Closed | -$329K | – | 2720 |
|
|
2024
Q4 | $329K | Buy |
+44,220
| New | +$329K | ﹤0.01% | 2099 |
|
|
2023
Q4 | – | Sell |
-259,113
| Closed | -$2.07M | – | 1982 |
|
|
2023
Q3 | $2.07M | Sell |
259,113
-117,718
| -31% | -$941K | 0.02% | 686 |
|
|
2023
Q2 | $3.28M | Sell |
376,831
-110,739
| -23% | -$963K | 0.04% | 431 |
|
|
2023
Q1 | $1.43M | Sell |
487,570
-67,962
| -12% | -$200K | 0.02% | 736 |
|
|
2022
Q4 | $1.94M | Sell |
555,532
-9,019
| -2% | -$31.6K | 0.03% | 537 |
|
|
2022
Q3 | $4.47M | Buy |
564,551
+26,982
| +5% | +$213K | 0.05% | 409 |
|
|
2022
Q2 | $4.23M | Buy |
537,569
+80,351
| +18% | +$632K | 0.08% | 304 |
|
|
2022
Q1 | $5.56M | Buy |
457,218
+141,069
| +45% | +$1.71M | 0.07% | 245 |
|
|
2021
Q4 | $3.87M | Buy |
+316,149
| New | +$3.87M | 0.03% | 353 |
|
|
2019
Q2 | – | Sell |
-49,817
| Closed | -$892K | – | 1056 |
|
|
2019
Q1 | $892K | Buy |
+49,817
| New | +$892K | 0.03% | 387 |
|